Terms: = Lung cancer AND CDK12, KIAA0904, CRKRS, 51755, ENSG00000167258, CRK7, CRKR, Q9NYV4 AND Prognosis
4 results:
1. cdk12 loss inhibits cell proliferation by regulating TBK1 in non-small cell lung cancer cells.
Liu X; Liu Y; Chai W; Yan M; Li H; Li J; Sun L; Cao Y; Liu Q; Sun Y; Pan H
Mol Cell Probes; 2023 Oct; 71():101923. PubMed ID: 37517598
[TBL] [Abstract] [Full Text] [Related]
2. Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract] [Full Text] [Related]
3. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
[TBL] [Abstract] [Full Text] [Related]
4. cdk12 Promotes Breast cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling.
Peng F; Yang C; Kong Y; Huang X; Chen Y; Zhou Y; Xie X; Liu P
Curr Cancer Drug Targets; 2020; 20(2):156-165. PubMed ID: 31744448
[TBL] [Abstract] [Full Text] [Related]
